Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (144)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Honda, K.
Right arrow Articles by Horiuchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honda, K.
Right arrow Articles by Horiuchi, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 14, Issue 6 1541-1549, Copyright © 1999 by Oxford University Press


ORIGINAL ARTICLES

Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration

K Honda, K Nitta, S Horita, W Yumura, H Nihei, R Nagai, K Ikeda and S Horiuchi
Department of Medicine, Kidney Center, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162, Japan; Department of Biochemistry, Kumamoto University School of Medicine, Kumamoto, Japan; Corresponding author

Background: Ultra-filtration failure is a serious complication of long-term continuous ambulatory peritoneal dialysis (CAPD). This complication is related to histological changes of the peritoneum, i.e. severe interstitial fibrosis and microvascular sclerosis. Although their pathogenesis had not been elucidated yet, advanced glycation end products (AGEs) have been shown to accumulate in the peritoneal tissue of CAPD patients. Methods: Peritoneal biopsy specimens from 14 CAPD patients with low ultra-filtration (n=9) and high ultrafiltration (n=5) capacity were immunohistochemically investigated using a monoclonal antibody against AGEs (6D12). The severity of peritoneal fibrosis, microvascular sclerosis and intensity of AGE accumulation were semi-quantitatively evaluated. Peritoneal ultra-filtration capacity was evaluated by calculating daily ultrafiltration volume per bodyweight (UFV/BW) and D/D0 (glucose) of the peritoneal equilibration test. Results: In all patients with low ultra-filtration, AGE accumulated in the peritoneal fibrous tissue and microvascular walls. Remarkably, AGE accumulated more intensely in hyalinized fibrosis of small venular media. Extent of AGE accumulation in peritoneal interstitium and vascular walls correlated with the progression of interstitial fibrosis (&rgr;=0.727, P=0.0088) and vascular sclerosis (&rgr;=0.915, P=0.001). UFV/BW was inversely correlated to interstitial fibrosis (&rgr;=-0.660, P=0.0174), microvascular sclerosis (&rgr;=-0.671, P=0.0155) and microvascular sclerosis (&rgr;=-0.671, P=0.0145). Conclusions: In CAPD patients, AGE formation in the peritoneum correlates with the development of severe interstitial fibrosis and microvascular sclerosis, which is associated clinically with impaired peritoneal ultra-filtration. Key words: advanced glycation end product; continuous ambulatory peritoneal dialysis; peritoneal fibrosis; ultra-filtration failure; vascular changes
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Nakao, K. Nakao, Y. Takatori, S. Kojo, J. Inoue, S. Akagi, H. Sugiyama, J. Wada, and H. Makino
Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy
Nephrol. Dial. Transplant., September 16, 2009; (2009) gfp479v1.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
H. Nishimura, O. Ikehara, T. Naito, C. Higuchi, and T. Sanaka
EVALUATION OF TAURINE AS AN OSMOTIC AGENT FOR PERITONEAL DIALYSIS SOLUTION
Perit. Dial. Int., March 1, 2009; 29(2): 204 - 216.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
S. Duman and S. Sen
TECHNICAL ASPECTS IN STUDYING PERITONEAL MORPHOLOGY IN ANIMAL MODELS OF PERITONEAL DIALYSIS
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S40 - S44.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
N. Rabbani and P. J. Thornalley
QUANTITATION OF MARKERS OF PROTEIN DAMAGE BY GLYCATION, OXIDATION, AND NITRATION IN PERITONEAL DIALYSIS
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S51 - S56.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. Honda, C. Hamada, M. Nakayama, M. Miyazaki, A. M. Sherif, T. Harada, H. Hirano, and on behalf of the Peritoneal Biopsy Study Group of
Impact of Uremia, Diabetes, and Peritoneal Dialysis Itself on the Pathogenesis of Peritoneal Sclerosis: A Quantitative Study of Peritoneal Membrane Morphology
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 720 - 728.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
K. Kaneko, C. Hamada, and Y. Tomino
PERITONEAL FIBROSIS INTERVENTION
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S82 - S86.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. S. De Vriese, R. G. Tilton, S. Mortier, and N. H. Lameire
Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2549 - 2555.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. M. Sherif, M. Nakayama, Y. Maruyama, H. Yoshida, H. Yamamoto, K. Yokoyama, and M. Kawakami
Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1675 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. Schwenger, C. Morath, A. Salava, K. Amann, Y. Seregin, R. Deppisch, E. Ritz, A. Bierhaus, P. P. Nawroth, and M. Zeier
Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-Products
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Agalou, N. Ahmed, R. Babaei-Jadidi, A. Dawnay, and P. J. Thornalley
Profound Mishandling of Protein Glycation Degradation Products in Uremia and Dialysis
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1471 - 1485.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Zareie, E. D. Keuning, P. M. ter Wee, R. H. J. Beelen, and J. van den Born
Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats
Nephrol. Dial. Transplant., January 1, 2005; 20(1): 189 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Nakamura and T. Niwa
Pyridoxal Phosphate and Hepatocyte Growth Factor Prevent Dialysate-Induced Peritoneal Damage
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 144 - 150.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Y. Yamaji, Y. Nakazato, N. Oshima, M. Hayashi, and T. Saruta
Oxidative stress induced by iron released from transferrin in low pH peritoneal dialysis solution
Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2592 - 2597.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Fusshoeller, M. Plail, B. Grabensee, and J. Plum
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study
Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2101 - 2106.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. A. Sjoland, R. Smith Pedersen, J. Jespersen, and J. Gram
Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1264 - 1268.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Fischbach, J. Terzic, S. Chauve, V. Laugel, A. Muller, and B. Haraldsson
Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 925 - 932.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. S. De Vriese, A. Flyvbjerg, S. Mortier, R. G. Tilton, and N. H. Lameire
Inhibition of the Interaction of AGE-RAGE Prevents Hyperglycemia-Induced Fibrosis of the Peritoneal Membrane
J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2109 - 2118.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. D. Williams, K. J. Craig, N. Topley, C. Von Ruhland, M. Fallon, G. R. Newman, R. K. Mackenzie, and G. T. Williams
Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 470 - 479.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Mortier, A. S. De Vriese, J. Van de Voorde, T. P. Schaub, J. Passlick-Deetjen, and N. H. Lameire
Hemodynamic Effects of Peritoneal Dialysis Solutions on the Rat Peritoneal Membrane: Role of Acidity, Buffer Choice, Glucose Concentration, and Glucose Degradation Products
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 480 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Jones, C. J. Holmes, R. K. Mackenzie, R. Stead, G. A. Coles, J. D. Williams, D. Faict, and N. Topley
Continuous Dialysis with Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids Results in a Long-Term Improvement in Ex Vivo Peritoneal Macrophage Function
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S97 - 103.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Gokal
Peritoneal Dialysis in the 21st Century: An Analysis of Current Problems and Future Developments
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S104 - 115.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. M. Hoff and T. R. Shockley
Peritoneal Dialysis in the 21st Century: The Potential of Gene Therapy
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S117 - 124.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. S. D. Vriese, S. Mortier, and N. H. Lameire
Glucotoxicity of the peritoneal membrane: the case for VEGF
Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2299 - 2302.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Ogata, N. Yorioka, and N. Kohno
Glucose and Prednisolone Alter Basic Fibroblast Growth Factor Expression in Peritoneal Mesothelial Cells and Fibroblasts
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2787 - 2796.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. S. De Vriese, S. Mortier, and N. H. Lameire
Neoangiogenesis in the peritoneal membrane: does it play a role in ultrafiltration failure?
Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2143 - 2145.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. J. MARGETTS, M. KOLB, T. GALT, C. M. HOFF, T. R. SHOCKLEY, and J. GAULDIE
Gene Transfer of Transforming Growth Factor-{beta}1 to the Rat Peritoneum: Effects on Membrane Function
J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2029 - 2039.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. N. LAI, F. K. LI, H. YUI LAN, S. TANG, A. W. L. TSANG, D. T. M. CHAN, and J. C. LEUNG
Expression of Aquaporin-1 in Human Peritoneal Mesothelial Cells and Its Upregulation by Glucose In Vitro
J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1036 - 1045.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
S. J. DAVIES, L. PHILLIPS, P. F. NAISH, and G. I. RUSSELL
Peritoneal Glucose Exposure and Changes in Membrane Solute Transport with Time on Peritoneal Dialysis
J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1046 - 1051.
[Abstract] [Full Text]


Home page
Nephrol Dial TransplantHome page
S. J. Davies
Peritoneal solute transport--we know it is important, but what is it?
Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1120 - 1123.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.